Antisense composition and method for treatment of CMV infection
First Claim
Patent Images
1. A method for treating CMV retinitis comprising administering by intravitreal injection an effective amount of a composition comprising an antisense oligonucleotide targeted to CMV IE2 and a pharmaceutically acceptable carrier to an animal having CMV retinitis.
0 Assignments
0 Petitions
Accused Products
Abstract
This invention concerns compositions and methods for the treatment of CMV infections. A composition including an antisense oligonucleotide targeted to the IE2 gene of CMV and a pharmaceutically acceptable carrier were used stop progression in CMV retinitis.
9 Citations
4 Claims
-
1. A method for treating CMV retinitis comprising administering by intravitreal injection an effective amount of a composition comprising an antisense oligonucleotide targeted to CMV IE2 and a pharmaceutically acceptable carrier to an animal having CMV retinitis.
- 2. A composition comprising an antisense oligonucleotide targeted to CMV IE2 and a pharmaceutically acceptable carrier.
Specification